pharmaceuticals

Pfizer and BioNTech each saw gains on Thursday after the companies announced additional details regarding their collaboration in the fight against COVID-19.
Chris Lange
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
Paul Ausick
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
Chris Lange
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
Chris Lange
Amarin has been right in the middle of this recent market sell-off, and while shares have been halved, the stock could be poised for a strong recovery. All the pieces seem to be there.
Chris Lange
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
BioNTech stock jumped on Tuesday and went even higher early on Wednesday. This comes after the company announced a collaboration with the pharmaceutical giant Pfizer.
Chris Lange
Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments...
Paul Ausick
The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical stocks decreased.
Chris Lange
Shares of Amarin have plunged in recent months. Even more troubling, there appears to no catalyst to drive them higher.
Douglas A. McIntyre
One of the biggest concerns in the financial markets at this time is that governments and central banks have few obvious policy tools to help keep their economies going if what was seen in China...
Jon C. Ogg
Mylan stock pulled back on Friday after it reported mixed fourth-quarter financial results late Thursday.
Chris Lange
The February 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chris Lange
The broad markets are getting crushed on Monday on renewed fears of the spread of the coronavirus (Covid-19). But a handful of stocks were acting as a natural hedge to the virus news.
Chris Lange